Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-13 11:48:34 UTC |
---|
Update Date | 2023-02-21 17:29:03 UTC |
---|
HMDB ID | HMDB0041931 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 3,4-Methylenedioxyamphetamine |
---|
Description | An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [PubChem]; In 1970, the Controlled Substances Act was enacted in the United States, placing MDA into Schedule I. It is similarly controlled in other nations. In Canada MDA is a Schedule III drug. Internationally, MDA is a Schedule I drug under the Convention on Psychotropic Substances. Many similar unscheduled MDxx chemicals can be prosecuted under the Federal Analog Act. MDA (3,4-methylenedioxyamphetamine), also known as tenamfetamine (INN), is a psychedelic and entactogenic drug of the phenethylamine and amphetamine chemical classes. It is mainly used as a recreational drug, an entheogen, and a tool in use to supplement various types of practices for transcendence, including in meditation, psychonautics, and as an agent in psychedelic psychotherapy. It was first synthesized by G. Mannish and W. Jacobson in 1910. There are about 20 different synthetic routes described in the literature for its preparation. |
---|
Structure | InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3 |
---|
Synonyms | Value | Source |
---|
(RS)-3,4-(Methylenedioxy)methamphetamine | HMDB | 1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine | HMDB | 1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine | HMDB | 3,4-Methylenedioxymethamphetamine | HMDB | DL-(3,4-Methylenedioxy)methamphetamine | HMDB | MDMA | HMDB | N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine | HMDB | N-Methyl-3,4-methylenedioxyamphetamine | HMDB | 3,4 Methylenedioxyamphetamine | HMDB | 3,4-Methylenedioxyamphetamine | MeSH |
|
---|
Chemical Formula | C10H13NO2 |
---|
Average Molecular Weight | 179.2157 |
---|
Monoisotopic Molecular Weight | 179.094628665 |
---|
IUPAC Name | 1-(2H-1,3-benzodioxol-5-yl)propan-2-amine |
---|
Traditional Name | 3,4-methylenedioxyamphetamine |
---|
CAS Registry Number | 4764-17-4 |
---|
SMILES | CC(N)CC1=CC2=C(OCO2)C=C1 |
---|
InChI Identifier | InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3 |
---|
InChI Key | NGBBVGZWCFBOGO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzodioxoles. These are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodioxoles |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzodioxoles |
---|
Alternative Parents | |
---|
Substituents | - Benzodioxole
- Aralkylamine
- Benzenoid
- Oxacycle
- Acetal
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 1.64 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3,4-Methylenedioxyamphetamine,1TMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N[Si](C)(C)C | 1644.3 | Semi standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,1TMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N[Si](C)(C)C | 1639.3 | Standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,2TMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N([Si](C)(C)C)[Si](C)(C)C | 1853.0 | Semi standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,2TMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N([Si](C)(C)C)[Si](C)(C)C | 1860.6 | Standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,1TBDMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N[Si](C)(C)C(C)(C)C | 1887.9 | Semi standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,1TBDMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N[Si](C)(C)C(C)(C)C | 1859.3 | Standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,2TBDMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2289.7 | Semi standard non polar | 33892256 | 3,4-Methylenedioxyamphetamine,2TBDMS,isomer #1 | CC(CC1=CC=C2OCOC2=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2331.2 | Standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3,4-Methylenedioxyamphetamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9700000000-694a0e98e0007bd9b883 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,4-Methylenedioxyamphetamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-03di-0900000000-ceb833ad1eb42d11bf4a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-03di-0900000000-7795b35d40550ca1ea10 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-03ei-0900000000-510f32fec3a45da3afe8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-0a5i-0900000000-5ba589950b29c036e6af | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-0a4r-2900000000-7d9cec73d2dd144096d7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-0a6r-4900000000-56ce80af24db379bcf90 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-0fb9-9500000000-7c78e7d8dc85b9c6aa0d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-0fba-9200000000-9b312e42e8f1bd38d687 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine LC-ESI-QFT , positive-QTOF | splash10-0udi-9100000000-38f4dd19df31aa785f14 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 150V, Positive-QTOF | splash10-0fba-9200000000-e71b359c869f7c1b90b3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 120V, Positive-QTOF | splash10-0fb9-9500000000-b52b9c038a0be1fb60fb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 30V, Positive-QTOF | splash10-03di-0900000000-5b4b266fdfaf116d2c11 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 15V, Positive-QTOF | splash10-03di-0900000000-90c6f023c050512edfef | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 60V, Positive-QTOF | splash10-0a5i-0900000000-c1ffbc132d48fa5323ea | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 45V, Positive-QTOF | splash10-03ei-0900000000-0d18c49ffda39eba1719 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 75V, Positive-QTOF | splash10-0a4r-2900000000-a27f93991861f1d8e5bf | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 90V, Positive-QTOF | splash10-0a6r-4900000000-e8157165c79492e6d982 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 10V, Positive-QTOF | splash10-01q9-0900000000-fe189983d8867c5fb48c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 20V, Positive-QTOF | splash10-03e9-0900000000-a862d6061554e1fa09b2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 40V, Positive-QTOF | splash10-0159-4900000000-29f75fdee1c2f4da927b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 10V, Negative-QTOF | splash10-004i-0900000000-314837a1ce6decec2206 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 20V, Negative-QTOF | splash10-004i-0900000000-a60d0f65c4417be99e02 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 40V, Negative-QTOF | splash10-03di-2900000000-d922e1321d8e07817cec | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 10V, Negative-QTOF | splash10-004r-0900000000-999b93a28fc3d3d7837e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,4-Methylenedioxyamphetamine 20V, Negative-QTOF | splash10-01t9-0900000000-70f106f29fa8e6b618a3 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+) | 2022-02-11 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
---|